What is Leeymada-50?
Leeymada-50 is an advanced cardiovascular medication used for the management of chronic heart failure. It is a fixed-dose combination of Sacubitril (24mg) and Valsartan (26mg), totaling 50mg of active ingredients. As an Angiotensin Receptor-Neprilysin Inhibitor (ARNI), it works by reducing the strain on the heart and improving its ability to pump blood effectively.
Benefits and Uses
Leeymada-50 is specifically indicated for adult patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. The dual-action formula helps to:
- Relax blood vessels to improve blood flow.
- Reduce the risk of cardiovascular death and hospitalization.
- Decrease symptoms associated with heart failure, such as shortness of breath and fatigue.
Dosage and Administration
Leeymada-50 is typically taken twice daily, with or without food, as directed by your cardiologist. It is essential to follow the prescribed dosage consistently. If you are switching from an ACE inhibitor, a "washout period" of 36 hours is required before starting Leeymada to prevent serious side effects.
Is Leeymada a generic for Uperio?
Yes, Leeymada-50 contains the same active ingredients (Sacubitril/Valsartan) as the brand-name medication Uperio. It serves as a cost-effective alternative for patients in Nigeria requiring long-term heart failure management.
Precautions and Side Effects
Inform your healthcare provider if you have a history of angioedema, kidney disease, or liver problems. Common side effects may include low blood pressure (hypotension), cough, or high potassium levels. Always consult a GoMed pharmacist or your doctor for personalized advice.